How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

New method to tune LLMs is RLMF, reinforcement learning with metacognitive feedback. It is akin to RLAIF and somewhat like ...

Press’ post set off a firestorm of controversy within the Haskell community, which is small but vocal, and likely felt the ...

In “Dog Days,” LaBarge blurs the lines between memoir and criticism. Over the course of a career, what a critic trains her ...

Malay essay writing constitutes a critical yet persistently challenging competency for students in Malaysian Independent Chinese Secondary Schools (MICSS), where Mandarin serves as the primary medium ...

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

As they scramble to keep their systems online, AI companies are making things expensive for the rest of us. Large language ...

Intactis Bio joins the Biocomputing industry, which seeks to deliver lower-energy, cost-efficient computing capacity driven ...

This past summer has seen major updates in the burgeoning relationship between the U.S. government and developers of the ...

We all have an internal list of those we still don't understand, let alone appreciate. We all have biases, even prejudices, toward specific groups. In our workshops we ask people to gather in pairs ...